X-linked dominant inheritance
|
phenotype |
|
Finding
|
65
|
|
0.100 |
None |
|
0 |
|
|
|
X- linked recessive
|
phenotype |
|
Finding
|
172
|
1
|
0.100 |
None |
|
0 |
|
|
|
Wiskott-Aldrich Syndrome
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Immune System Diseases; Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
95
|
34
|
0.020 |
None |
0.500 |
2 |
|
1980 |
1980 |
VITILIGO-ASSOCIATED MULTIPLE AUTOIMMUNE DISEASE SUSCEPTIBILITY 1 (finding)
|
disease |
Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
302
|
92
|
0.010 |
None |
< 0.001 |
1 |
|
1982 |
1982 |
Vitiligo
|
disease |
Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
395
|
249
|
0.010 |
None |
< 0.001 |
1 |
|
1982 |
1982 |
Vitamin A Deficiency
|
disease |
Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
51
|
1
|
0.010 |
None |
1.000 |
1 |
|
2008 |
2008 |
Virus Diseases
|
group |
Infections
|
Disease or Syndrome
|
1471
|
42
|
0.020 |
None |
1.000 |
2 |
|
1988 |
2007 |
Vascular Diseases
|
group |
Cardiovascular Diseases
|
Disease or Syndrome
|
688
|
40
|
0.020 |
None |
0.500 |
2 |
|
2012 |
2017 |
Urinary symptoms
|
phenotype |
|
Sign or Symptom
|
10
|
|
0.010 |
None |
1.000 |
1 |
|
2010 |
2010 |
Uridine monophosphate hydrolase deficiency
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
2
|
|
0.010 |
None |
1.000 |
1 |
|
1982 |
1982 |
Upper Respiratory Infections
|
group |
Infections; Respiratory Tract Diseases
|
Disease or Syndrome
|
64
|
6
|
0.020 |
None |
1.000 |
2 |
|
1981 |
1988 |
Unconjugated hyperbilirubinemia
|
disease |
Pathological Conditions, Signs and Symptoms
|
Disease or Syndrome
|
23
|
4
|
0.130 |
None |
1.000 |
3 |
|
2002 |
2017 |
Tumor Progression
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Neoplastic Process
|
3865
|
72
|
0.040 |
None |
1.000 |
4 |
|
2014 |
2019 |
Tumor Cell Invasion
|
phenotype |
|
Neoplastic Process
|
6626
|
169
|
0.040 |
None |
1.000 |
4 |
|
1989 |
2019 |
Triple-Negative Breast Carcinoma
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
1598
|
96
|
0.010 |
None |
1.000 |
1 |
|
2016 |
2016 |
Triple Negative Breast Neoplasms
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
1674
|
99
|
0.010 |
None |
1.000 |
1 |
|
2016 |
2016 |
Transient Ischemic Attack
|
disease |
Nervous System Diseases; Cardiovascular Diseases
|
Disease or Syndrome
|
344
|
16
|
0.200 |
None |
1.000 |
1 |
|
2012 |
2012 |
Transferrin saturation measurement
|
phenotype |
|
Laboratory Procedure
|
26
|
36
|
0.100 |
None |
1.000 |
1 |
1
|
2017 |
2017 |
Thyroid carcinoma
|
disease |
Neoplasms; Endocrine System Diseases
|
Neoplastic Process
|
1175
|
145
|
0.010 |
None |
1.000 |
1 |
|
1978 |
1978 |
Thymoma
|
disease |
Neoplasms; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
291
|
20
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Thrombocythemia, Essential
|
disease |
Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
220
|
37
|
0.020 |
None |
1.000 |
2 |
|
1982 |
1983 |
Thalassemia trait
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
10
|
2
|
0.020 |
None |
1.000 |
2 |
|
1995 |
2000 |
Thalassemia
|
group |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
136
|
18
|
0.060 |
None |
1.000 |
6 |
|
1980 |
2019 |
Steatohepatitis
|
disease |
Digestive System Diseases
|
Disease or Syndrome
|
1143
|
75
|
0.020 |
None |
1.000 |
2 |
|
2018 |
2020 |
Squamous cell carcinoma of esophagus
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
2053
|
329
|
0.010 |
None |
1.000 |
1 |
|
2015 |
2015 |